Victory For Sick Child: Company Will Give Him Drug

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Courtesy: WREG image from NDN video

MEMPHIS–The Chimerix pharmaceutical company said it will give 7-year-old Josh Hardy a drug that could help him survive as part of a pilot trial.

WREG reported the company will send the drug within the next 48 hours.

In a statement posted on WREG’s website, St. Jude said, “This drug is experimental and has not yet been approved by the FDA and the safety and effectiveness of the medication has not yet been established for use in children. For this reason, it will be administered under a new treatment protocol as approved by a committee charged with compliance to federal and institutional regulations for clinical research (IRB). It is also important to understand that this remains a critical and complex medical situation.”

Josh is a patient in the intensive care unit at St. Jude.

A virus is destroying his heart and kidney.

Originally, the drug company refused to give the drug to Josh saying helping him would hurt others.

*Read more from our sister station in Memphis, WREG*

14 comments

Comments are closed.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.